Company Filing History:
Years Active: 2016
Title: Qixian Chen: Innovator in Nucleic Acid Delivery
Introduction
Qixian Chen is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of nucleic acid delivery. His innovative work focuses on improving the efficiency and safety of nucleic acid introduction into cells.
Latest Patents
Qixian Chen holds a patent for a "Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery." This patent presents an excellent nucleic acid delivery composition that has reduced cytotoxicity and improved nucleic acid introduction efficiency and gene expression efficiency. The composition comprises a block copolymer with an uncharged hydrophilic polymer segment and a cationic polymer segment, a cationic polymer, and a nucleic acid. The mol percentage (B/H ratio) of the cationic groups of the block copolymer to the total cationic groups of the block copolymer and the cationic polymer is between 25% and 90%.
Career Highlights
Qixian Chen is affiliated with The University of Tokyo, where he continues to advance research in his field. His work has garnered attention for its potential applications in gene therapy and other medical treatments.
Collaborations
Some of his notable coworkers include Kazunori Kataoka and Takehiko Ishii, who have also made significant contributions to the field of pharmaceutical sciences.
Conclusion
Qixian Chen's innovative work in nucleic acid delivery compositions highlights his commitment to advancing medical science. His contributions are paving the way for more effective and safer therapeutic options in the future.